API man­u­fac­tur­er in Chi­na hand­ed warn­ing let­ter af­ter fail­ing to re­spond to the reg­u­la­tor’s re­quests for in­for­ma­tion

An ac­tive phar­ma­ceu­ti­cal in­gre­di­ent man­u­fac­tur­er in Chi­na re­port­ed­ly lied to the FDA about whether it will con­tin­ue ship­ping prod­ucts in­to the US and did not …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER